The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.

@article{Viktorin2014TheRO,
  title={The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.},
  author={Alexander Viktorin and Paul Lichtenstein and Michael E. Thase and Henrik Larsson and Cecilia Lundholm and Patrik K. E. Magnusson and Mika{\'e}l Land{\'e}n},
  journal={The American journal of psychiatry},
  year={2014},
  volume={171 10},
  pages={
          1067-73
        }
}
OBJECTIVE This study examined the risk of antidepressant-induced manic switch in patients with bipolar disorder treated either with antidepressant monotherapy or with an antidepressant in conjunction with a mood stabilizer. METHOD Using Swedish national registries, the authors identified 3,240 patients with bipolar disorder who started treatment with an antidepressant and had no antidepressant treatment during the previous year. Patients were categorized into those receiving antidepressant… 

Figures and Tables from this paper

Risk of manic switch with antidepressants use in patients with bipolar disorder in a Nigerian neuropsychiatric hospital
  • A. Fela-Thomas, O. S. Olotu, O. Esan
  • Psychology, Medicine
    The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa
  • 2018
TLDR
A large proportion of patients with BAD on antidepressants experience medication-induced manic or hypomanic switch, and there was no significant difference in the rate of MS in either those treated with adjunct antidepressants therapy with a mood stabiliser or an antipsychotic or those placed on a combination of antidepressants, antipsychotics and mood-stabilising agents.
The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
TLDR
No evidence was found for a positive association between methylphenidate and treatment-emergent mania among patients with bipolar disorder who were concomitantly receiving a mood-stabilizing medication.
Antidepressant Treatment and Manic Switch in Bipolar I Disorder: A Clinical and Molecular Genetic Study
TLDR
Investigation of the effects of individual genomics and antidepressant medication on the risk of manic switch in bipolar I disorder found that antidepressant medication and rs10262219 variants jointly increased the riskof manic switch after bipolar depression.
Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study
TLDR
The results show an increase in the proportion of patients with bipolar disorder being treated with antidepressants in the period from 1997 to 2012, however, the extent of antidepressant monotherapy decreased during the same period.
Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.
TLDR
The authors review the literature concerning efficacy and safety of use of antidepressants in the treatment of affective disorders and long-term impact on the course of the disease and decide whether antidepressant monotherapy is allowed in severe depression.
Epidemiological studies of medication use and effectiveness in bipolar disorder
TLDR
Findings indicate that efforts to reduce treatment delay should especially target patients who are naïve to moodstabilizers and antipsychotics or diagnosed with BD during a brief hospitalization, and that combination therapies including lithium, valproate and quetiapine or olanzapine were associated with the lowest risks of treatment failure.
Treatments and outcomes in bipolar disorder
TLDR
The unique position of lithium in bipolar disorder treatment is underline and the impact of CYP2C19 polymorphisms on antidepressant treatment patterns as well as the risk for treatment emergent mania is studied using a large sample of patients with bipolar disorder.
Changes in mood stabilizer prescription patterns in bipolar disorder.
Clinical characteristics of antidepressant use and related manic switch in bipolar disorder
TLDR
It is suggested that the risk of manic switch is especially prominent in the first months of AD use, and Antidepressants use in combining it with a mood stabilizers (MS) may not be adequate in preventing switches in shorter terms.
...
...

References

SHOWING 1-10 OF 35 REFERENCES
Risk factors for antidepressant-related switch to mania.
TLDR
Bipolar patients with an earlier age at onset and an illness course characterized by lower rate of response to antidepressants and higher rate of switches into mania or hypomania were found to be the ones with higher switch risk.
Antidepressant-induced mania in bipolar patients: identification of risk factors.
TLDR
The frequency of mood switching associated with acute antidepressant therapy may be reduced by lithium treatment, and particular attention should be paid to patients with a hyperthymic temperament, who have a greater risk of mood switches.
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
TLDR
Antidepressants are associated with the potential risk for treatment-emergent mania or hypomania, particularly in bipolar patients with short illness duration, multiple past antidepressant trials, and past experience of switch with at least one antidepressant.
Bipolar depression and antidepressant-induced mania: a naturalistic study.
TLDR
The frequency and severity of postdepressive mood elevation associated with acute or continuation antidepressant therapy may be reduced by mood stabilizers, which may be more likely in patients with a strong history of mania.
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers
TLDR
The authors examined the comparative risks of switches in mood polarity into hypomania or mania during acute and continuation trials of adjunctive antidepressant treatment of bipolar depression by using clinician-rated daily reports of mood-associated dysfunction on the National Institute of Mental Health Life Chart Method.
Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
TLDR
Both treatments appeared to be effective; however, the addition of an antidepressant may have greater clinical utility in the treatment of bipolar depression.
Antidepressant-induced mania and cycle acceleration: a controversy revisited.
TLDR
Antidepressant-induced mania may be a marker for increased vulnerability to antidepressant-induced cycle acceleration and is associated with younger age at first treatment and may be more likely to occur in women and in bipolar II patients.
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Antidepressant-induced mania: an overview of current controversies.
TLDR
About one-quarter to one-third of bipolar patients may be inherently susceptible to antidepressant-induced manias, and bipolar patients with a strong genetic loading for bipolar illness whose initial illness begins in adolescence or young adulthood may be especially at risk.
...
...